Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

ClinicalTrials.gov ID: NCT06041269

Public ClinicalTrials.gov record NCT06041269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 5, 2026, 7:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)

Study identification

NCT ID
NCT06041269
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AnaptysBio, Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2023 (Actual)
Primary completion
Nov 29, 2024 (Estimated)
Completion
May 30, 2025 (Estimated)
Last update posted
Nov 25, 2024

2023 – 2025

United States locations

U.S. sites
36
U.S. states
12
U.S. cities
34
Facility City State ZIP Site status
AnaptysBio Investigative Site 10-132 Flagstaff Arizona 86001 —
AnaptysBio Investigative Site 10-130 Glendale Arizona 85306 —
AnaptysBio Investigative Site 10-129 Phoenix Arizona 85037 —
AnaptysBio Investigative Site 10-131 Tucson Arizona 85704 —
AnaptysBio Investigative Site 10-105 Covina California 91722 —
Anaptys Bio Investigative Site 10-119 Rancho Mirage California 92270 —
AnaptysBio Investigative Site 10-113 San Diego California 92108 —
AnaptysBio Investigative Site 10-127 San Francisco California 94123 —
AnaptysBio Investigative Site 10-136 Temecula California 92592 —
AnaptysBio Investigative Site 10-133 Upland California 91786 —
AnaptysBio Investigative Site 10-112 Whitter California 90602 —
AnaptysBio Investigative Site 10-103 Aventura Florida 33180 —
AnaptysBio Investigative Site 10-141 Avon Park Florida 33825 —
AnaptysBio Investigative Site 10-118 Boynton Beach Florida 33436 —
AnaptysBio Investigative Site 10-125 Daytona Beach Florida 32117 —
AnaptysBio Investigative Site 10-122 Homestead Florida 33032 —
Anaptys Bio Investigative Site 10-142 Miami Florida 33125 —
AnaptysBio Investigative Site 10-140 Miami Florida 33126 —
AnaptysBio Investigative Site 10-102 Miami Florida 33155 —
AnaptysBio Investigative Site 10-124 Plantation Florida 33324 —
AnaptysBio Investigative Site 10-139 West Palm Beach Florida 33407 —
AnaptysBio Investigative Site 10-114 Chicago Illinois 60640 —
AnaptysBio Investigative Site 10-145 Monroe Louisiana 71203 —
AnaptysBio Investigative Site 10-143 Brookline Massachusetts 02445 —
AnaptysBio Investigative Site 10-116 Albuquerque New Mexico 87102 —
AnaptysBio Investigative Site 10-148 Smithfield North Carolina 27577 —
AnaptysBio Investigative Site 10-146 Middleburg Heights Ohio 44130 —
AnaptysBio Investigative Site 10-101 Jackson Tennessee 38305 —
AnaptysBio Investigative Site 10-120 Allen Texas 75013 —
AnaptysBio Investigative Site 10-107 Colleyville Texas 76034 —
AnaptysBio Investigative Site 10-123 Katy Texas 77450 —
AnaptysBio Investigative Site 10-108 Mesquite Texas 75150 —
AnaptysBio Investigative Site 10-110 Plano Texas 75024 —
AnaptysBio Investigative Site 10-106 The Woodlands Texas 77382 —
AnaptysBio Investigative Site 10-121 Tomball Texas 77375 —
AnaptysBio Investigative Site 10-117 Beckley West Virginia 25801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06041269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2024 · Synced Oct 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06041269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →